CURE’s kidney cancer page is an extensive resource of cancer information featuring the latest kidney cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on kidney cancer.
March 23rd 2020
The first study to look at cancer prevalence in transgender people and examine the health of transgender cancer survivors also found concerning health trends among transgender women and gender nonconforming people.
March 20th 2020
Young Investigator and Advanced Discovery Awards will advance kidney cancer research, as the Kidney Cancer Association opens up its grant applications.
March 11th 2020
African American race was associated with longer survival in non-clear cell metastatic renal cell carcinoma compared with Hispanic and Caucasian patients.
February 28th 2020
From New Jersey Governor Phil Murphy announcing he will undergo surgery to remove a potentially cancerous tumor on his kidney to an NHL team granting a 15-year-old fan with cancer the ultimate wish, here’s what is making headlines in the cancer space this week.
February 26th 2020
Utilizing the data of the CheckMate 9ER trial, researchers believe that combination therapies in the treatment of patients with renal cell carcinoma are the future of the landscape.
February 25th 2020
Here’s a look at what’s inside our 2020 Winter issue.
February 24th 2020
Treatments for renal cell carcinoma are showing effectiveness in the short term, but with the help of new trials, researchers are looking to expand their impact for long term treatment.
February 24th 2020
The landscape for patients with renal cell carcinoma could potentially change as the use of immune checkpoint inhibition shows promise for these patients.
February 19th 2020
MK-6482 demonstrated an objective response rate of 24% among patients with advanced clear cell renal cell carcinoma, according to study findings presented at the 2020 Genitourinary Cancers Symposium.
February 18th 2020
After five years of follow-up, treatment with Opdivo in those with previously treated advanced or metastatic renal cell carcinoma induced superior survival outcomes.
February 18th 2020
More than 50% of patients with previously untreated advanced or metastatic renal cell carcinoma were alive at 42 months after being treated with Opdivo plus Yervoy.
February 13th 2020
Children with higher birth weight and body mass index, as well as taller height, are at a greater risk of developing renal cell carcinoma later in life, according to new study findings.
January 15th 2020
Findings from a recent study supported further evaluation of comparing anti–PD-1 to anti–PD-L1 therapy to help determine treatment options for patients with cancer.
January 14th 2020
Personalized treatments have changed the cancer landscape, and continue to change it for patients with renal cell carcinoma.
January 9th 2020
A physician’s social network is important to determining the adoption of high-value cancer drugs, as researchers have determined peer influence had a strong association with the adoption of Avastin among oncologists across the nation.
January 8th 2020
Doing a few hours of exercise per week can help prevent kidney, liver, endometrial, colon and breast cancers, as well as multiple myeloma and non-Hodgkin lymphoma, a large study found.
December 11th 2019
The Food and Drug Administration approved the first generic for Afinitor, which can provide a safe, effective, lower cost alternative to the brand-name drug it references.
December 10th 2019
A phase 3 clinical trial investigating Fotivda improved chances of preventing disease progression in patients with kidney cancer compared with Nexavar.
December 7th 2019
Here is a list of clinical trials that are currently happening within the kidney cancer space.
December 5th 2019
In cancer clinical trials, the goal, or primary endpoint, is often focused on overall survival. However, one expert from the Dana Farber Cancer Institute thinks treatment-free survival should also be documented to provide patients with the data they need to make informed treatment choices.
November 9th 2019
When asked about the future of renal cell carcinoma (RCC) treatment, one expert is hopeful about the current search, but notes that more work is needed to find a reliable biomarker for use in patients with the most common kind of kidney cancer.
November 3rd 2019
The field of kidney cancer treatment could soon be expanding thanks to the inclusion of PARP inhibitors, vaccination-based strategies and emerging therapies such as Fotivda (tivozanib), according to research presented at the 2019 Kidney Cancer Research Summit.
October 21st 2019
Dr. Camillo Porta discussed what is new in kidney cancer beyond the first line of treatment at A Vision of Hope: A Kidney Cancer Educational Symposium.
October 17th 2019
Drug duos that hit kidney cancer with immunotherapy and targeted treatment offer a better alternative to single agents.
October 17th 2019
Those with non-clear cell kidney cancer have much to look forward to as oncologists’ understanding of the disease is evolving.
October 16th 2019
Pre- and post-surgical treatment could benefit patients with kidney cancer who are at high risk for disease recurrence.
October 14th 2019
One patient advocate explained how patients with renal cell carcinoma can query about clinical trials and what they need to know about them to do so.
October 12th 2019
Nutrition plays a key role in kidney cancer; however, the need to address it is still unmet.